New Lantern

Founded in 2021 and based in California, US, New Lantern operates as a medical technology company that offers artificial intelligence-based imaging solutions to radiology departments, hospitals, and medical practitioners. In November 2024, New Lantern raised USD 19 million in series A funding led by investor Benchmark, with participation from other investors Afore Capital, Menlo Ventures, SV Angel, and Neo Ventures. The firm, as of November 2024, has a client base that encompasses various healthcare institutions across North America and Europe, and is led by its founder and CEO, Shiva Suri. The company offers a cloud-based Picture Archiving and Communication System (PACS) designed to enhance the workflow of radiologists by leveraging artificial intelligence (AI).

The core product, the Lantern PACS, features a modern interface, unified worklist, and proprietary cloud-native viewer. It integrates an AI reporter toolkit that automates dictation tasks, allowing radiologists to save significant time during their shifts. The system also includes capabilities such as automatic image segmentation, one-click volumetric measurements, adaptive hanging protocols tailored to individual preferences, and a smart worklist that distributes cases based on specialty. The company will use the November 2024 funding to advance its R&D programs and hire new members of its engineering and sales departments.

It is also targeting expansion into key markets across Europe and Asia by the end of 2025.